Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bhirundra Balgobin"'
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 11 (2021)
Background Treatment with clozapine requires regular blood monitoring in order to minimise the risk of agranulocytosis. The demands on patients and clinicians associated with monitoring may be reduced by using point-of-care, as opposed to lab-based a
Externí odkaz:
https://doaj.org/article/9c766a60c32e4ff3b6f68d49ac6bf294
Autor:
Matthew Atkins, Philip McGuire, Bhirundra Balgobin, Sophie Williams, Fatou Ceesay, Neville Desouza, Pravinkumar Patel, David Taylor
Publikováno v:
Journal of Laboratory Medicine. 46:187-193
Objectives Patients treated with clozapine are required to have regular venous blood samples taken to measure white blood cell (WBC) and neutrophil counts to reduce the risk of agranulocytosis. The need for regular venous blood sampling can deter pat
Publikováno v:
Journal of psychiatric research. 157
Clozapine treatment requires regular full blood counts (FBC) because of the risk of agranulocytosis. Traditionally, FBCs use venous blood samples but the need for frequent venepuncture adversely affects adherence. We investigated the utility of a poi
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 11 (2021)
Therapeutic Advances in Psychopharmacology
Therapeutic Advances in Psychopharmacology
Background Treatment with clozapine requires regular blood monitoring in order to minimise the risk of agranulocytosis. The demands on patients and clinicians associated with monitoring may be reduced by using point-of-care, as opposed to lab-based a